Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

0.24

Margin Of Safety %

9

Put/Call OI Ratio

0.45

EPS Next Q Diff

-0.13

EPS Last/This Y

2.24

EPS This/Next Y

0.55

Price

69.84

Target Price

92.46

Analyst Recom

1.37

Performance Q

-4.1

Relative Volume

0.59

Beta

0.38

Ticker: AZN




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02AZN71.930.340.15176926
2025-06-03AZN71.860.330.32184803
2025-06-04AZN730.350.34185493
2025-06-05AZN72.360.350.55185543
2025-06-06AZN72.870.361.10195804
2025-06-09AZN72.990.370.87187745
2025-06-10AZN73.830.370.47188318
2025-06-11AZN73.750.381.03189310
2025-06-12AZN750.380.48192024
2025-06-13AZN74.420.390.03191710
2025-06-16AZN73.550.390.45186571
2025-06-17AZN70.970.390.32188373
2025-06-18AZN70.750.371.45195542
2025-06-20AZN69.950.370.34197261
2025-06-23AZN70.640.410.31128226
2025-06-24AZN70.560.419.16131981
2025-06-25AZN69.690.535.80143532
2025-06-26AZN70.060.480.18140404
2025-06-27AZN69.850.451.43146670
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02AZN71.9315.34681.94.51
2025-06-03AZN71.8215.34697.94.51
2025-06-04AZN73.0015.34991.24.51
2025-06-05AZN72.3515.34722.24.51
2025-06-06AZN72.8815.34854.04.51
2025-06-09AZN73.0115.34771.54.51
2025-06-10AZN73.8215.34954.44.51
2025-06-11AZN73.7515.34791.64.51
2025-06-12AZN75.0015.35036.74.51
2025-06-13AZN74.4115.34703.84.51
2025-06-16AZN73.5515.34535.94.51
2025-06-17AZN70.9815.34324.74.51
2025-06-18AZN70.7615.34478.94.51
2025-06-20AZN69.9515.34607.44.51
2025-06-23AZN70.6515.34906.84.51
2025-06-24AZN70.5515.34891.74.51
2025-06-25AZN69.7015.34726.54.51
2025-06-26AZN70.0615.34837.44.51
2025-06-27AZN69.8415.34861.14.51
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02AZN0.000.590.24
2025-06-03AZN0.000.590.24
2025-06-04AZN0.000.590.24
2025-06-05AZN0.000.590.24
2025-06-06AZN0.000.590.24
2025-06-09AZN0.000.570.24
2025-06-10AZN0.000.570.24
2025-06-11AZN0.000.570.22
2025-06-12AZN0.000.570.22
2025-06-13AZN0.000.570.22
2025-06-16AZN0.000.900.22
2025-06-18AZN0.000.900.22
2025-06-20AZN0.000.900.22
2025-06-23AZN0.000.870.22
2025-06-24AZN0.000.870.22
2025-06-25AZN0.000.870.22
2025-06-26AZN0.000.870.24
2025-06-27AZN0.000.870.24
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

1.24

Avg. EPS Est. Current Quarter

1.14

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

Institutional Transactions

0.87

Beta

0.38

Average Sales Estimate Current Quarter

14112

Average Sales Estimate Next Quarter

14578

Fair Value

76.13

Quality Score

93

Growth Score

95

Sentiment Score

52

Actual DrawDown %

20.3

Max Drawdown 5-Year %

-27.9

Target Price

92.46

P/E

28.06

Forward P/E

13.7

PEG

2.47

P/S

3.94

P/B

5.28

P/Free Cash Flow

18.89

EPS

2.49

Average EPS Est. Cur. Y​

4.51

EPS Next Y. (Est.)

5.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14.14

Relative Volume

0.59

Return on Equity vs Sector %

-5

Return on Equity vs Industry %

-13.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.09

EBIT Estimation

4861.1
Astrazeneca PLC
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 94300
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; and a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
stock quote shares AZN – AstraZeneca PLC Stock Price stock today
news today AZN – AstraZeneca PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch AZN – AstraZeneca PLC yahoo finance google finance
stock history AZN – AstraZeneca PLC invest stock market
stock prices AZN premarket after hours
ticker AZN fair value insiders trading